A higher intake of sodium is known to increase the risk of cardiovascular (CV) diseases such as heart attack and stroke, owing to its blood pressure (BP) increasing effects. 1,2 The harmful effects of dietary salt on arterial structure and function, in addition to inducing the development of hypertension, have also been demonstrated. [3] [4] [5] However, there are emerging controversies regarding an adequate intake level for daily sodium based on recent studies reporting a J-shaped association between sodium excretion and CV events, which means that both low and high sodium excretion were associated with an increased CV risk. 6-8 Even more surprising, an inverse association was found between sodium excretion and CV mortality. 9 On the basis of these conflicting results, although the World Health Organization recommends an intake of <2.0 g sodium/day, 10 others argue that there is no sufficient body of evidence to suggest that a universal reduction of sodium intake could improve health outcomes. In addition to these inconsistent CV mortality results, several recent studies 
assessing the relations between sodium excretion and changes in CV target organs have yielded conflicting results. [11] [12] [13] [14] According to Guyton's hypothesis, in normotensive persons, a transient increase in BP due to excess sodium loading is physiologically managed by the normal kidney function to maintain a normal BP. 15 Accordingly, the studies on the association between salt intake and CV health outcomes may need to be individualized on the basis of BP assessment.
Increased left ventricular (LV) mass index, LV function, carotid intima-media thickness (CIMT), and brachial-ankle pulse wave velocity (baPWV) are associated with CV mortality and morbidity, even in the asymptomatic population. [16] [17] [18] To clarify the effect of sodium excretion on CV target organs, we comprehensively evaluated whether sodium excretion is associated with CV structural and functional changes, by using tissue Doppler echocardiography, carotid ultrasound, and baPWV measurements, in a nonhypertensive population.
METHODS

Study population
Previous reports have described the enrollment of a study population from the Ansan cohort, which is a populationbased cohort included in the ongoing Korean Genome and Epidemiology Study. 19 For this cross-sectional study, we selected cohort members who participated in the fourth 2-year follow-up study from 12 March 2007 to 15 April 2009. All participants completed a comprehensive health examination, including answering interviewer-administered questionnaires, anthropometric measurements, laboratory assessment for CV risk factors, and CV imaging evaluations. Among a total of 3,255 participants, we only enrolled nonhypertensive persons (n = 2,362) with a systolic BP of <140 mm Hg and a diastolic BP of <90 mm Hg after at least a 5-minute period of rest in the sitting position and with no use of antihypertensive medication. BP measurements were repeated twice after a 30-second interval, and the average value of 2 readings of systolic and diastolic BPs was used. The exclusion criteria were as follows: age 70 years or older (n = 79), preexisting CV disease including significant valvular heart diseases and arrhythmia (n = 46), chronic renal disease or a serum creatinine level >1.5 mg/dl (n = 5), unavailable urinary sodium data (n = 239), and inadequate data of tissue Doppler echocardiography, carotid ultrasound, or baPWV (n = 648). We also excluded participants with an ejection fraction of <55% after echocardiography (n = 19), leaving 1,586 subjects (806 men and 780 women) for the analysis. This study was approved by the Human Subjects Review Committee of the Korea University Ansan Hospital, and written informed consent was obtained from all participants.
Measurement of urinary sodium
All participants fasted for at least 8 hours. Urine samples were collected in the morning after the first-void urine. To estimate 24-hour urinary sodium excretion from the spot urine specimens, we used Tanaka's prediction model, which was developed for and validated in the Asian population. 20 This formula is also known to be useful for estimating the population mean levels of 24-hour sodium excretion irrespective of the urine collection time. 21 Urinary sodium excretion was expressed as mEq/day.
Tissue Doppler echocardiography
Standard echocardiography was performed by a commercially available ultrasound machine (Vivid 7; GE Vingmed, Horton, Norway) with a 3.5-MHz transducer in the left lateral decubitus position according to the American Society of Echocardiography guidelines. The left atrial anteroposterior diameter was measured by using the M-mode of the parasternal long axis view. The LV ejection fraction was calculated by using the modified biplane Simpson's method. The LV mass was determined according to the Devereux formula, normalized for body surface area and expressed as an index (g/m 2 ). The systolic (Sa) and early diastolic (Ea) velocities were measured at the septal mitral annulus. The mitral E/Ea ratio, as an index of LV diastolic filling pressure, was subsequently calculated. All measurements were performed by one investigator who was blinded to all clinical data.
Carotid ultrasound
Right and left CIMT measurements were performed by using B-mode ultrasonography (SonoSite TITAN; SonoSite, Bothell, WA) with a 7.5-MHz linear-array transducer. CIMT images were recorded at far and near walls approximately 1 cm proximal to the bifurcation on both sides. The mean CIMT value was calculated by averaging the left and right CIMT values obtained from the near and far walls, by using a semi-automated software (M' ATH SR version 2.0; Metris, Argenteuil, France). The coefficients of variation between and within trained sonographers were <5%.
Pulse wave velocity
The baPWV was measured with an automatic volumeplethysmographic device (VP-2000; Colin, Komaki, Japan) in the supine position after a minimum of 5-minute rest. The PWV was calculated as the distance between the 2 sites over the pulse transit time. The time interval between the brachium and the ankle was defined as the time interval between the wave front of the brachial waveform and that of the ankle waveform. The distance between the sampling points of the baPWV was calculated automatically according to the height of the subjects. The mean baPWV value of the left and right sides was used for the analysis.
Statistical analysis
The results are expressed as mean ± SD for continuous variables or as percentages for categorical variables. The differences in characteristics among the 3 different categories according to tertiles of estimated 24-hour urinary sodium excretion were compared by using 1-way analysis of variance or the chi-square test. Partial correlation coefficients were calculated to estimate the relationship between systolic and diastolic BPs and urinary sodium excretion after controlling for age, sex, waist circumference, heart rate, diabetes mellitus, antidiabetic treatment, alcohol consumption, smoking status, high-sensitivity C-reactive protein, and total cholesterol. Echocardiographic data, CIMT, and baPWV were compared by using 1-way analysis of covariance of general linear models. The least square means and standard errors for CV structural and functional variables were measured after controlling for age, sex, waist circumference, systolic BP, heart rate, diabetes mellitus, antidiabetic treatment, alcohol consumption, smoking status, high-sensitivity C-reactive protein, and total cholesterol. To explore the independent relation between estimated 24-hour urinary sodium excretion and CV structure and function (dependent variables), we performed a multiple linear regression analysis. On the basis of clinical relevance and univariate analysis, the following multivariate models were tested: (i) models adjusting for age, sex, and waist circumference and (ii) models adjusting for age, sex, waist circumference, systolic BP, heart rate, diabetes mellitus, antidiabetic treatment, alcohol consumption, smoking status, high-sensitivity C-reactive protein, and total cholesterol. A P value of <0.05 was considered statistically significant. All statistical analyses were performed with SAS statistical software (SAS 9.1.3; SAS Institute, Cary, NC).
RESULTS
The demographic and clinical characteristics of the study sample according to tertiles of urinary sodium excretion are shown in Table 1 . The overall mean ± SD of the estimated 24-hour urinary sodium excretion was 156 ± 34 mEq/day. Men showed a higher estimated 24-hour urinary sodium excretion than women (158 ± 35 mEq/day vs. 154 ± 33 mEq/ day, P = 0.029). Participants with a higher estimated 24-hour urinary sodium excretion were more likely to be men and have higher body mass index, waist circumference, systolic and diastolic BPs, fasting blood glucose, and blood levels of triglycerides.
Partial correlation analysis indicated that systolic (r = 0.163, P < 0.001) and diastolic (r = 0.125, P < 0.001) BPs were positively and independently correlated with urinary sodium excretion. Table 2 shows the associations of estimated 24-hour urinary sodium excretion with echocardiographic measurements. In this model adjusted for age, sex, waist circumference, systolic BP, heart rate, diabetes mellitus, antidiabetic treatment, alcohol consumption, smoking status, high-sensitivity C-reactive protein, and total cholesterol, there was no statistically significant trend in any parameters of LV structure and function across the tertiles of the estimated 24-hour urinary sodium excretion. In contrast to the relation between LV changes and urinary sodium, there were statistically significant stepwise decreases in the baPWV (P for trend = 0.003) and CIMT (P for trend = 0.001) values as the estimated 24-hour urinary sodium excretion increased in multivariate analyses (Figure 1 ). In addition, urinary sodium excretion was independently associated with baPWV and CIMT, but not with LV structural and functional parameters in multiple linear regression analyses (Table 3) .
Because we did not find any associations between urinary sodium excretion and LV parameters, we estimated our statistical power to detect a significant magnitude of candidate predictor. Assuming that R 2 of only adjusted factors in multiple linear regression model ranges from 0.25 to 0.30, statistical power to detect 0.0038 or 0.005 improvement of R 2 with an additional predictor was estimated to be 80% and 90%. These minimal detectable values were extremely small.
DISCUSSION
In this population-based sample of nonhypertensives, we found an inverse association between urinary sodium excretion and vascular structure and function, evaluated with baPWV and CIMT, whereas there were no associations between urinary sodium excretion and LV size or function.
The current recommendation for controlling BP and reducing the risk of CV diseases is still a generalized reduction of salt intake (<5 g/day) at the population level, 10 which reflects a direct linear relation between sodium intake and CV morbimortality. 22 However, 2 observational follow-up studies clearly represented a typical J-shaped curve by demonstrating that both high sodium excretion (>7 g/day) and low sodium intake (<3 g/day) were associated with increased CV mortality. 6, 23 In addition, in the recent Flemish Study on Genes, Environment, and Health Outcomes/European Project on Genes in Hypertension (FLEMENGHO/EPOGH) cohort studies, 9 despite the positive and independent correlation between systolic BP and sodium excretion, low sodium excretion (mean 2.3 g/day) predicted a high CV mortality. In our study, the mean levels according to tertiles of urinary sodium excretion (2.7, 3.5, and 4.4 g/day, respectively) were similar to the data of those cohort studies, and the lowest tertile group was associated with the highest value of vascular parameters despite the positive relation between BP and urinary sodium excretion. Although the FLEMENGHO/EPOGH cohorts failed to show an increased CV risk in participants with high sodium excretion, they seem to provide enough evidence to raise the issue of a "safe range" in relation to salt intake, like for other nutrients. 24, 25 As a result, the existence of a "safe zone" and the possibility of adverse effects of low sodium are emerging issues in the relation between salt intake and health outcomes.
Considering that the presence of target organ damage is associated with CV events, the assessment of the effect of salt Figure 1 . Multivariate-adjusted mean values of brachial-ankle pulse wave velocity (baPWV) and common carotid intima-media thickness (CIMT) after adjustment for age, sex, waist circumference, systolic blood pressure, heart rate, diabetes mellitus, antidiabetic treatment, alcohol consumption, smoking status, high-sensitivity C-reactive protein, and total cholesterol. Bars represent the SEM. Abbreviation: NS, not significant. intake on CV structure and function would provide a clue to reveal the association between salt intake and CV health. Unfortunately, however, previous studies also provide inconsistent results like those for CV morbimortality. Positive linear relations with higher sodium intake were observed in CIMT, PWV, augmentation index, or central pulse pressure in a variety of study populations. 3, 4, 26 Additionally, several studies have demonstrated that dietary salt reduction leads to significant improvements in PWV or endotheliumdependent vasodilation in addition to significant BP reduction or regardless of the BP. [26] [27] [28] [29] On the other hand, to our knowledge, 2 previous reports found a J-shaped or an inverse relation between sodium intake and vascular structure and function, 11, 12 which is similar to some recent reports about the effects of salt intake on CV morbimortality. One study described a typical J-shaped relation between sodium intake and vascular parameters, particularly for PWV and CIMT. They suggested that CV risk factors seem to play an important role, on the basis of a complete J-shaped curve between salt intake and CIMT after the adjustment for age. The other study found an inverse between the carotid and aortic augmentation indices and 24-hour urinary sodium excretion, which was consistent in both cross-sectional and longitudinal analyses. In their study, they explained that the presence of an inverse association in lieu of a J-shaped curve might be because the average 24-hour urinary sodium excretion was about 4 g/day, which is in the safe zone range (2.5-6.0 g/day). Our findings are consistent with these results and extended the inverse relation to PWV and CIMT. Unfortunately, because most of the participants in our study consumed <6 g sodium per day (mean, 3.6 g/day), we also could not find a J-shaped curve between salt intake and vascular parameters. Although some researchers cast doubt on the role of low salt-induced neurohormonal or metabolic changes, the underlying mechanisms for the harmful effect of low salt intake include elevated sympathetic nervous activity, activated renin-angiotensin system, increased aldosterone secretion and blood lipid level, and decreased insulin sensitivity. It remains uncertain whether a change in these neurohormones could lead to vascular damage and CV events against BP reduction through a low salt intake. However, a recent review has shown that sodium reduction resulted in a significant increase in the plasma levels of renin, aldosterone, adrenalin, noradrenaline, cholesterol (2.5%), and triglyceride (7%), whereas the reduction of BP with low salt intake was only 1% in normotensives compared to 3.5% in hypertensives. 30 Furthermore, dietary salt loading did not increase the PWV values and BP by Guyton's pressure-natriuresis hypothesis to BP regulation in normotensive persons 31 and even a high sodium excretion was not associated with increased risk of death and CV events in participants without hypertension. 6 In the least, these data do not support the current recommendations of a generalized and indiscriminate reduction of salt intake, especially in nonhypertensives. In our study, because blood lipid levels were comparable or even low in low sodium excretion, activation of the renin-angiotensin-aldosterone system and/or the increase in sympathetic activity may be the underlying mechanisms explaining the inverse association between estimated sodium excretion and vascular structure and function. Concerning the effects of dietary sodium intake on LV structure, several studies provided conflicting results. 13, [32] [33] [34] Some have noticed a significant direct relation between dietary salt intake and LV mass, especially in hypertensives. 33, 34 Considering that the prevalence of salt sensitivity is relatively higher in the hypertensive than in the normotensive population, 35 positive relations between sodium excretion and LV mass may be observed more frequently in hypertensives than in normotensives. However, others failed to verify a positive association between sodium excretion and LV mass, even in high BP status. 13, 36, 37 To our knowledge, a few studies have reported about the effect of salt intake on LV function, 13, 38, 39 and only one study demonstrated that sodium excretion was the strongest independent determinant of impaired LV diastolic function in early essential hypertension. 38 However, this trial had a small sample size, and the assessment of LV diastolic function was performed only by using the conventional Doppler parameters that are load dependent. On the contrary, we failed to find a significant association between urinary sodium excretion and LV function in a relatively large sample size, even with the tissue Doppler imaging as a more sensitive technique to detect early and subtle changes in LV performance. Further studies are needed to explain the different effects of low sodium excretion on the heart and blood vessels.
The present study has several limitations. First, the use of cross-sectional study design in a general population with a low risk for CVD did not allow us to establish longitudinal relations between sodium and CV changes. Second, given that there were ethnic differences in the association between urinary sodium excretion and LV mass, the results from a single ethnic group cannot be generalized to other ethnicities. Third, we used spot urine samples instead of 24-hour urine collection for the estimation of salt intake. Although 24-hour urine collection is known to be the gold standard in measuring sodium excretion, the use of a formula for estimating 24-hour urinary sodium excretion is accepted as an alternative measurement method at the population level. 40 Finally, our data could not include residual confounding factors such as salt sensitivity and genetic determinants of renal sodium excretion.
In conclusion, we observed significant inverse associations between urinary sodium excretion and vascular structure and function in our community-based sample of nonhypertensives in spite of linear relationship between sodium excretion and BP. Further longitudinal studies are required to explore the underlying mechanism and to confirm whether our finding extends to CV morbidity and mortality.
